On March 5, Japan unveiled new NHI prices for the FY2024 drug price revision. A Jiho survey found that Tsumura, a specialist in Japanese Kampo herbal medicines, received an astonishing raise of over 24% in its drug prices on a…
HOME > BUSINESS
BUSINESS
- GSK’s Aldreb Debuts as Last Resort for Multidrug Resistant Pseudomonas Aeruginosa Infection
May 26, 2015
- Masanobu Suzuki Tapped as President of Nippon Kayaku
May 26, 2015
- Chugai Files NDA for Combination Psoriasis Vulgaris Drug
May 26, 2015
- Celgene Launches Multiple Myeloma Treatment Pomalyst; Keio Professor Acknowledges Its Efficacy in PFS, OS Improvement
May 26, 2015
- Sales Increase 19.3% for 3 Generic-Only Makers; Incentive for DPC Hospitals Spurs Growth
May 25, 2015
- Ken Masuo to Become Japan Representative for Oncology Business: AZ
May 25, 2015
- Blopress AG Share Tops 60% in Generic Market, Aims for Further Growth: ASKA President Yamaguchi
May 25, 2015
- 180 Billion Yen Sales in FY2017 Is “Quite Reachable”: Meiji Seika Pharma President
May 22, 2015
- Oncologics Retain Top Position in Therapeutic Category Sales Ranking in FY2014: IMS
May 22, 2015
- Japan Pharma Market Down by 0.6% to Under 10 Trillion Yen in FY2014: IMS
May 22, 2015
- Sales of SGLT-2 Inhibitors Were Sluggish in FY2014, but Expected to Pick Up with Lifting of 14-Day Prescription Limit
May 21, 2015
- “4-Company Oligopoly” on Seasonal Flu Vaccines Coming to an End, Era of Mega-Competition Coming to Japan: Dr Yamanishi of BIKEN
May 21, 2015
- Daiichi Sankyo, Takeda to Join in Distribution of Kaketsuken’s Seasonal Influenza Vaccine “to Bolster Stable Supplies”
May 21, 2015
- Otsuka to Launch Abilify Intramuscular Injectable on May 25
May 21, 2015
- Eisai Makes World’s 2nd Launch of Lenvima for Thyroid Cancer in Japan following US
May 21, 2015
- Gilead to Launch Sovaldi on May 25, with Proper Use Promotion by 150 Sales Reps
May 21, 2015
- Top 4 Drug Wholesalers Report 0.82% Operating Profit Rate in FY2014
May 20, 2015
- R-Tech Ueno Ties Up with Hokkaido University to Develop VAP-1 Inhibitor
May 20, 2015
- Quintiles Acquires Clio Science to Enhance Oncology, CNS Expertise
May 20, 2015
- Biogen Japan Sets to Quadruple Sales in 2 Years: New Chief
May 19, 2015
ページ
Too often, recruiters are more clear on what a position will “do” rather than what it will “achieve”.Outlining tasks and responsibilities takes priority over goals and impact.But to attract top talent, you need to define and explain what success looks…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…